Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Anogen Life Sciences
AddedFeb 18, 2024
UpdatedJun 18, 2026
Anogen Life Sciences

Anogen Life Sciences

Anogen Life Sciences enhances drug efficacy with its innovative sustained release delivery system, improving vision and preventing blindness.

HQ
St. Petersburg, FL, US
Founded
2006
Overview
Compare
Fundraising
Employees

ALS is a developer of a sustained release drug delivery system designed for the local delivery of biologic and small molecule drugs.

The company's system is a sustained release drug delivery system that is designed to significantly enhance and improve the therapeutic characteristics of new and approved drugs, enabling medical practitioners to improve vision and prevent blindness with the use of these therapeutic systems. Anogen Life Sciences was founded in 2006 and is based in St. Petersburg, FL.

Anogen Life Sciences - Similar Companies

AnkyrBio logo

AnkyrBio

ankyrbio.com

Mati Therapeutics logo

Mati Therapeutics

Zenomics logo

Zenomics

InSitu Biologics logo

InSitu Biologics

Optimeos Life Sciences logo

Optimeos Life Sciences

optimeos.com

Vitranu logo

Vitranu

vitranu.com

Okogen logo

Okogen

okogen.com

Anagenex logo

Anagenex

anagenex.com

Sonoran Biosciences logo

Sonoran Biosciences

Transparency Life Sciences logo

Transparency Life Sciences

Trilogic Pharma logo

Trilogic Pharma

trilogicpharma.com

AnaBios logo

AnaBios

anabios.com

Toralgen logo

Toralgen

toralgen.com

Replenish logo

Replenish

Talima Therapeutics logo

Talima Therapeutics

talima.com

Anogen Life Sciences - Quick Facts

Who are Anogen Life Sciences' competitors?

Companies similar to Anogen Life Sciences include AnkyrBio, Mati Therapeutics, Zenomics and InSitu Biologics.

When was Anogen Life Sciences founded?

Anogen Life Sciences was founded in 2006.

Where is Anogen Life Sciences' headquarters located?

Anogen Life Sciences' headquarters is located in St. Petersburg, FL, US.

When was Anogen Life Sciences' last funding round?

Anogen Life Sciences' most recent funding round was for $407.6k (USD) in February 2021.

How much has Anogen Life Sciences raised to-date?

As of Feb 5, 2021, Anogen Life Sciences has raised a total of $407.6k (USD).

How many employees does Anogen Life Sciences have?

Anogen Life Sciences has 30 employees as of Feb 4, 2024.

Anogen Life Sciences - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Delivery
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified